The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 3.00
Ask: 3.10
Change: -0.05 (-1.61%)
Spread: 0.10 (3.333%)
Open: 3.10
High: 3.15
Low: 3.05
Prev. Close: 3.10
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Aug 2020 14:49

RNS Number : 9761U
ValiRx PLC
03 August 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Valirx PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Monecor (London) Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

31/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

03/08/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.413

-

6.413

54,062,373

Position of previous notification (if

applicable)

8.86

8.86

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

GB00BLH13C52

 

3,466,989

-

6.413

-

SUBTOTAL 8. A

3,466,989

6.413

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, UK

Date of completion

03/08/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUOSORRWUWRAR
Date   Source Headline
2nd May 200811:35 amRNSResult of EGM
30th Apr 20087:00 amRNSTotal Voting Rights
7th Apr 20085:13 pmRNSNotice of EGM and Placing
18th Mar 20087:50 amPRNValibio Research Update
13th Feb 20087:55 amPRNLetter of Intent
29th Jan 20087:00 amPRNAustralian GeneICE Patent Granted
23rd Jan 20087:00 amPRNMorphogenesis Update
17th Jan 20087:00 amPRNGeneICE – CRT Research Update
31st Dec 20077:00 amRNSTotal Voting Rights
12th Dec 200711:08 amRNSCollaboration Update
12th Dec 20078:31 amPRNPhysiomics Collaboration Update
11th Dec 20077:00 amPRNValiBIO Update
27th Nov 20079:27 amPRNIssue of Equity
12th Nov 20077:00 amPRNEuropean Technology Patent for Nucleosomics
25th Oct 20074:00 pmPRNDirectorate Change
15th Oct 20077:00 amPRNLicense Agreement
28th Sep 200710:00 amPRNInterim Report
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20073:31 pmRNSIssue of Equity
21st Sep 20074:09 pmRNSPlacing
10th Sep 20077:00 amPRNGeneICE CRT update
17th Aug 20076:07 pmRNSAIM Rule 26 Information
8th Aug 20077:00 amPRNEuropean GeneICE Patent Granted and CRT Trials Update
31st Jul 20074:10 pmRNSTotal Voting Rights
27th Jul 200710:27 amRNSResult of AGM
19th Jul 20077:00 amPRNJoint Venture
18th Jul 20072:16 pmRNSIssue of Equity
25th Jun 20072:00 pmPRNFinal Results
12th Jun 200712:00 pmPRNValiRx partners with Clarity Imaging
14th May 20077:00 amPRNCRT / Cronos agreement extension
26th Apr 20077:00 amPRNUS GeneICE Patent Granted
18th Apr 20077:00 amPRNResearch & Development Update
4th Apr 20077:00 amPRNUniversity of Surrey - Collaborative Agreement
27th Mar 20073:45 pmRNSChange of address
15th Feb 20077:00 amPRNPhysiomics plc - Agreement
9th Jan 200712:10 pmPRNAppointment of Non-Executive Director
22nd Dec 200611:40 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSIntended Grant of Patent
4th Dec 20067:00 amRNSMorphogenesis Inc
3rd Oct 20067:00 amRNSAdditional Listing
2nd Oct 20062:33 pmRNSResult of EGM
29th Sep 20061:03 pmRNSConfirmation of Share Capital
26th Sep 20064:46 pmRNSInterim Results
18th Sep 20064:36 pmRNSSchedule 1 - Azure Holdings
11th Sep 20067:00 amRNSRestoration - Azure Holdings
11th Sep 20067:00 amRNSPropsd Aqstn & Notice of EGM
4th Aug 200611:06 amRNSConvertible Loan Note Offer
18th Jul 20063:48 pmRNSConvertible Loan Note Offer
29th Jun 200612:20 pmRNSFinal Results
8th Jun 20068:25 amRNSChange of registered office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.